Browse our anti-HGF (HGF) Antibodies

Full name:
anti-Hepatocyte Growth Factor (Hepapoietin A, Scatter Factor) Antibodies (HGF)
On www.antibodies-online.com are 261 Hepatocyte Growth Factor (Hepapoietin A, Scatter Factor) (HGF) Antibodies from 27 different suppliers available. Additionally we are shipping HGF Kits (121) and HGF Proteins (82) and many more products for this protein. A total of 481 HGF products are currently listed.
Synonyms:
AI838057, c-Met, C230052L06Rik, DFNB39, F-TCF, HGF, HGF/SF, HGFB, HGFR, HPTA, NK1, NK2, Par4, SF, SF/HGF

Most Popular Reactivities for anti-HGF (HGF) Antibodies

Select your species and application

anti-Mouse (Murine) HGF Antibodies:

anti-Rat (Rattus) HGF Antibodies:

anti-Human HGF Antibodies:

All available anti-HGF Antibodies

Go to our pre-filtered search.

Top referenced anti-HGF Antibodies

  1. Mouse (Murine) Polyclonal HGF Primary Antibody for WB - ABIN3042443 : Zhang, Wang, Ma, Liu, Zhang, Zhu: Effect of herba centellae on the expression of HGF and MCP-1. in Experimental and therapeutic medicine 2013 (PubMed)
    Show all 7 references for 3042443

  2. Human Polyclonal HGF Primary Antibody for FACS, IHC (p) - ABIN388462 : Ryugo, Sawa, Ono, Fukushima, Aleshin, Mizuno, Nakamura, Matsuda: Myocardial protective effect of human recombinant hepatocyte growth factor for prolonged heart graft preservation in rats. in Transplantation 2004 (PubMed)
    Show all 7 references for 388462

  3. Cow (Bovine) Polyclonal HGF Primary Antibody for IHC, WB - ABIN2781816 : Kitajima, Ide, Ohtsuka, Miyazaki: Induction of hepatocyte growth factor activator gene expression under hypoxia activates the hepatocyte growth factor/c-Met system via hypoxia inducible factor-1 in pancreatic cancer. in Cancer science 2008 (PubMed)
    Show all 6 references for 2781816

  4. Human Polyclonal HGF Primary Antibody for EIA, IHC (p) - ABIN357192 : Lyon, Deakin, Lietha, Gherardi, Gallagher et al.: The interactions of hepatocyte growth factor/scatter factor and its NK1 and NK2 variants with glycosaminoglycans using a modified gel mobility shift assay. Elucidation of the minimal size of binding ... in The Journal of biological chemistry 2004 (PubMed)
    Show all 5 references for 357192

  5. Human Polyclonal HGF Primary Antibody for IF (p), IHC (p) - ABIN736551 : Yu, He, Jiang, He, Fan, Wang, Geng, Dong: Expression and tissue distribution of hepatocyte growth factor (HGF) and its receptor (c-Met) in alpacas (Vicugna pacos) skins associated with white and brown coat colors. in Acta histochemica 2015 (PubMed)
    Show all 4 references for 736551

  6. Human Monoclonal HGF Primary Antibody for ELISA, IHC - ABIN251141 : Lin, Teo, Lam, Jeyaseelan, Wang: MicroRNA-10b pleiotropically regulates invasion, angiogenicity and apoptosis of tumor cells resembling mesenchymal subtype of glioblastoma multiforme. in Cell death & disease 2012 (PubMed)

  7. Human Monoclonal HGF Primary Antibody for IHC (p), IHC - ABIN438999 : Puzio-Kuter, Laddha, Castillo-Martin, Sun, Cordon-Cardo, Chan, Levine: Involvement of tumor suppressors PTEN and p53 in the formation of multiple subtypes of liposarcoma. in Cell death and differentiation 2015 (PubMed)

  8. Human Polyclonal HGF Primary Antibody for ELISA, IHC (p) - ABIN1996875 : Comoglio: Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells. in EXS 1993 (PubMed)

More Antibodies against HGF Interaction Partners

Mouse (Murine) Hepatocyte Growth Factor (Hepapoietin A, Scatter Factor) (HGF) interaction partners

  1. a c-Met/ETS-1 (show ETS1 Antibodies)/matrix metalloproteinase-14 (MMP-14 (show MMP14 Antibodies)) axis that controls VE-cadherin (show CDH5 Antibodies) degradation, endothelial mesenchymal transition, and vascular abnormality.

  2. Our results show that BMF (show BMF Antibodies)-derived IL-6/HGF and cancer cell-derived TGF-b1 mediate the interactions between bone marrow-derived myofibroblasts and gastric cancer cells, which regulate cancer stemness and promote tumorigenesis.

  3. We found the roles of hepatocyte growth factor (HGF) signaling in stria vascularis development for the first time and that lack of HGF signaling in the inner ear leads to profound hearing loss in the mouse. Our findings reveal a novel mechanism that may underlie human deafness DFNB39 and DFNB97. Our findings reveal an additional example of context-dependent c-MET signaling diversity, required here for proper cellular inva

  4. c-Met has been found to attenuate lung injury and apoptosis in bronchial epithelial cells.

  5. this study demonstrates an important role for HGF in the protective effects mediated by mesenchymal stromal cells in vivo in the bleomycin model of idiopathic pulmonary fibrosis

  6. In this paper, we demonstrate a potential biochemical mechanism for such phenomena by showing that c-Met receptors promote the tyrosine phosphorylation of RalGDS (show RALGDS Antibodies) at Y752 in its RBD (show CACNA1D Antibodies), which blocks the binding of Ras to RalGDS (show RALGDS Antibodies).

  7. HGF displays an antioxidant response by inducing the glutathione-related protection system.

  8. this study revealed that HB-EGF (show HBEGF Antibodies) as well as HGF inhibited BDL-induced cholestatic liver injury by predominantly exerting acute cytoprotective and chronic antifibrotic effects, respectively.

  9. The results suggest that PGRN (show GRN Antibodies) may affect the differentiation of retinal precursor cells to photoreceptor cells through the HGF receptor signaling pathway.

  10. study demonstrates that co-activation of AKT (show AKT1 Antibodies) and c-Met induces hepatocellular carcinoma development that depends on the mTORC1/FASN (show FASN Antibodies) pathway.

Human Hepatocyte Growth Factor (Hepapoietin A, Scatter Factor) (HGF) interaction partners

  1. Data suggest that HGF, IL-20 (show IL20 Antibodies), and IL-22 (show IL22 Antibodies) in the serum and bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC) patients before chemotherapy may be a prognostic of cancer progression.

  2. Studies indicate that the over-expression of hepatocyte growth factor (HGF) is valuable in colorectal cancer (CRC (show CALR Antibodies)) prognosis.

  3. These results establish HGF/C-Met as a central organizing signal in blood vessel-directed tumor cell migration in vivo and highlight a promising role for C-Met inhibitors in blocking tumor cell streaming and metastasis in vivo, and for use in human trials.

  4. Furthermore, activation of HGF/Met signaling increased the expression and transcriptional activity of FOXM1 (show FOXM1 Antibodies), and the cross talk between FOXM1 (show FOXM1 Antibodies) and HGF/Met signaling promoted pancreatic ductal adenocarcinoma (PDA)growth and resistance to Met inhibition

  5. These data suggest that paxillin (show PXN Antibodies) appears to influence major cell functions in a diverse range of prostate and breast cancer models. The responsiveness of cells to environmental factors such as HGF or BME may be influenced by paxillin (show PXN Antibodies) status, although this seems to be dependent on cell type

  6. Fibronectin (show FN1 Antibodies) and Hepatocyte Growth Factor were shown to be produced by lung fibroblasts and, furthermore, to enhance malignant pleural mesothelioma cell migration and invasion

  7. Glioblastoma patients with high expression of hepatocyte growth factor or unmethylated O(6)-methylguanine-DNA methyltransferase (show MGMT Antibodies) may benefit from onartuzumab plus bevacizumab chemotherapy.

  8. Plasma levels of HGF in PAH patients with mild disease were significantly higher than those in healthy controls, suggesting that plasma HGF has potential utility as a diagnostic biomarker for early PAH.

  9. Blood HGF was significantly higher in chronic hepatitis C patients with liver fibrosis compared to those without fibrosis.

  10. In summary, a decrease in VEGF-A (show VEGFA Antibodies) and an increase in sVEGFR1 during chemotherapy and bevacizumab exposure can contribute to both chemotherapy (due to c-MET/b-catenin activation) and bevacizumab (due to low VEGF (show VEGFA Antibodies) requirements) resistance. Because HGF levels decrease also during acquired resistance, alternative strategies to HGF-ligand inhibition should be investigated

Rabbit Hepatocyte Growth Factor (Hepapoietin A, Scatter Factor) (HGF) interaction partners

  1. acute pulmonary embolism associated with an enhanced HGF expression in the lungs, the right ventricle, and the liver

Cow (Bovine) Hepatocyte Growth Factor (Hepapoietin A, Scatter Factor) (HGF) interaction partners

  1. SNPs within bovine HGF gene were significantly associated with growth traits. This will provide a background for application of bovine HGF gene in the selection program in Chinese cattle.

  2. Treatment of the bovine satellite cells (BSC (show SLC12A2 Antibodies)) with ephrin-A5 (show EFNA5 Antibodies) causes a reduction in velocity with a concomitant increase in directed migration. Treatment of BSC (show SLC12A2 Antibodies) with hepatocyte growth factor had no immediate effect on cell motility or migration.

  3. HGF transiently increases gene transcription of angiotensin-converting enzyme (show ACE Antibodies)

Pig (Porcine) Hepatocyte Growth Factor (Hepapoietin A, Scatter Factor) (HGF) interaction partners

  1. Combined administration of mesenchymal stem cells overexpressing IGF-1 (show IGF1 Antibodies) and HGF enhances neovascularization but moderately improves cardiac regeneration in a porcine model.

  2. In an animal model of acute myocardial infarction relevant to human disease, intracoronary administration of IGF-1 (show IGF1 Antibodies)/hepatocyte growth factor (HGF) is a practical and effective strategy to reduce pathological cardiac remodeling.

HGF Antigen Profile

Antigen Summary

Hepatocyte growth factor regulates cell growth, cell motility, and morphogenesis by activating a tyrosine kinase signaling cascade after binding to the proto-oncogenic c-Met receptor. Hepatocyte growth factor is secreted by mesenchymal cells and acts as a multi-functional cytokine on cells of mainly epithelial origin. Its ability to stimulate mitogenesis, cell motility, and matrix invasion gives it a central role in angiogenesis, tumorogenesis, and tissue regeneration. It is secreted as a single inactive polypeptide and is cleaved by serine proteases into a 69-kDa alpha-chain and 34-kDa beta-chain. A disulfide bond between the alpha and beta chains produces the active, heterodimeric molecule. The protein belongs to the plasminogen subfamily of S1 peptidases but has no detectable protease activity. Alternative splicing of this gene produces multiple transcript variants encoding different isoforms.

Alternative names and synonyms associated with HGF

  • hepatocyte growth factor (HGF) antibody
  • hepatocyte growth factor (Hgf) antibody
  • hepatocyte growth factor (hepapoietin A; scatter factor) (HGF) antibody
  • hepatocyte growth factor (hepapoietin A; scatter factor) (Hgf) antibody
  • hepatocyte growth factor-like (LOC100525120) antibody
  • met proto-oncogene (Met) antibody
  • AI838057 antibody
  • c-Met antibody
  • C230052L06Rik antibody
  • DFNB39 antibody
  • F-TCF antibody
  • HGF antibody
  • HGF/SF antibody
  • HGFB antibody
  • HGFR antibody
  • HPTA antibody
  • NK1 antibody
  • NK2 antibody
  • Par4 antibody
  • SF antibody
  • SF/HGF antibody

Protein level used designations for HGF

hepatocyte growth factor , SF , hepatopoeitin-A , hepatopoietin-A , scatter factor , fibroblast-derived tumor cytotoxic factor , lung fibroblast-derived mitogen , hepapoietin A , HGF alpha-chain , hepatocyte growth factor /scatter factor , HGF receptor , HGF/SF receptor , SF receptor , hepatocyte growth factor receptor , met proto-oncogene tyrosine kinase , proto-oncogene c-Met , scatter factor receptor , tyrosine-protein kinase Met

GENE ID SPECIES
708316 Macaca mulatta
15234 Mus musculus
24446 Rattus norvegicus
3082 Homo sapiens
100730730 Cavia porcellus
100316908 Oryctolagus cuniculus
403441 Canis lupus familiaris
282879 Bos taurus
395941 Gallus gallus
493705 Felis catus
443075 Ovis aries
100525120 Sus scrofa
17295 Mus musculus
Selected quality suppliers for anti-HGF (HGF) Antibodies
Did you look for something else?